Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)
1 other identifier
interventional
14
1 country
1
Brief Summary
Anxiety and depression have been found to be significant co-occurring conditions in cancer patients. This study examines these and other psychological conditions in patients diagnosed with cholangiocarcinoma, a rare cancer of the bile duct, with an average survival time of three to six months post-diagnosis. Participants are taught EFT in telephone and internet group coaching sessions, and have access to an online support forum. They complete the Mini-Mental Adjustment to Cancer Scale (Mini-MAC), EORTC Quality of Life scale, the PTSD checklist, the Patient Health Questionnaire, and a brief health checklist. Participants also provide medical records confirming their diagnosis, and markers, both before and after the study. The study is expected to enroll 20-15 cholangiocarcinoma patients, and use a within-subjects, time series, repeated measures design. Symptoms are assessed prior to coaching, after four, and again after eight weekly coaching sessions. Follow-ups will occur in one month, three months, and one year. It is hypothesized that a drop in the severity of co-occurring psychological symptoms, pain and insomnia may occur after EFT coaching.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for early_phase_1 depression
Started Sep 2008
Longer than P75 for early_phase_1 depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 18, 2008
CompletedFirst Posted
Study publicly available on registry
August 19, 2008
CompletedStudy Start
First participant enrolled
September 20, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 23, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 25, 2028
April 27, 2026
April 1, 2026
19.6 years
August 18, 2008
April 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
depression
duration of study
Secondary Outcomes (3)
anxiety
duration of study
pain
duration of study
insomnia
duration of study
Study Arms (1)
1
EXPERIMENTALLifestyle Counseling with Emotional Freedom Techniques (EFT)
Interventions
Two series of four sessions of phone support group coaching instruction in the use of EFT
Eligibility Criteria
You may qualify if:
- Diagnosis of cholangiocarcinoma
- Ability to complete forms and attend phone coaching sessions
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Soul Medicine Institute
Santa Rosa, California, 95403, United States
Related Publications (1)
Endo I, Gonen M, Yopp AC, Dalal KM, Zhou Q, Klimstra D, D'Angelica M, DeMatteo RP, Fong Y, Schwartz L, Kemeny N, O'Reilly E, Abou-Alfa GK, Shimada H, Blumgart LH, Jarnagin WR. Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection. Ann Surg. 2008 Jul;248(1):84-96. doi: 10.1097/SLA.0b013e318176c4d3.
PMID: 18580211BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dawson Church, PhD
Soul Medicine Institute
Study Design
- Study Type
- interventional
- Phase
- early phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 18, 2008
First Posted
August 19, 2008
Study Start
September 20, 2008
Primary Completion (Estimated)
April 23, 2028
Study Completion (Estimated)
December 25, 2028
Last Updated
April 27, 2026
Record last verified: 2026-04